Histoplasmosis Relapse Rates Found Low in Study
Immunocompromised patients showed low relapse rates even when antifungal therapy was ended early.
U.S. Diseases — General
Recent news
September 23, 2026
Monopar Initiated Rolling NDA for ALXN1840Monopar Therapeutics began its rolling FDA submission for ALXN1840 to treat Wilson disease on July 22, 2026.
September 22, 2026
FDA Cleared Home Test for COVID, Flu, and RSVThe newly authorized diagnostic tool uses a single swab to detect four viral pathogens at once.
September 21, 2026
Researchers Developed Rapid Ebola and Lassa TestA new portable device can distinguish between Ebola and Lassa viruses using a single pin-prick blood sample.
September 19, 2026
Researchers Identified RNA Impact on MitochondriaA 2026 study discovered that excess RNA accumulation disrupts mitochondrial energy production.